Home » Health » Thoracic Aneurysm Growth: Surveillance Intervals & Risk Factors

Thoracic Aneurysm Growth: Surveillance Intervals & Risk Factors

by Dr. Michael Lee – Health Editor

Aortic ⁢Aneurysm Surveillance: New Data Refines Check-Up Intervals

ANN ARBOR, MI ⁤- A comprehensive meta-analysis of 85 studies published in the Journal of the American Heart ​Association in 2025 is prompting a⁣ re-evaluation of how frequently patients with thoracic aortic aneurysms⁣ should be monitored. the research,led by Dr. Matthew Henry of the University ⁢of Michigan, demonstrates that aneurysm growth rates vary significantly based​ on the underlying cause,⁢ directly impacting optimal⁤ surveillance strategies.

Thoracic​ aortic aneurysms ofen present without symptoms but carry a⁢ risk of potentially fatal rupture.Dr. Henry and his⁤ team categorized patients into three groups⁣ – those with ⁣hereditary aortic disease,⁤ those with bicuspid aortic valve disease, and those with sporadic aneurysms – to determine which characteristics correlate with faster aneurysm growth. The analysis included‍ data from ten studies on hereditary syndromes, 31 on bicuspid valve disease, and 34 on sporadic cases.

The⁣ study revealed substantial differences in annual ⁢growth rates.Aneurysms ​associated with genetic syndromes grew, on average,​ 0.25 mm per year, while those linked to Marfan syndrome expanded at 0.45 mm/year, and Loeys-Dietz syndrome at 0.81 mm/year. Patients‍ with bicuspid aortic valves experienced growth of 0.37 mm/year before ⁢surgery ‌and 0.18 mm/year afterward.Sporadic aneurysms of the ascending aorta ⁣grew at 0.33 mm/year, but ​those affecting‍ the descending aorta exhibited a significantly faster rate of 2.71 mm/year.

based on ⁤these findings,the authors suggest⁤ that asymptomatic patients without concerning morphological changes may require check-ups only every two to three years. However, individuals with ⁤Marfan or​ Loeys-Dietz syndrome, or those ⁤with aneurysms in the descending aorta, should be ⁣monitored more frequently due to their increased ⁣risk of rapid enlargement. ‌The research underscores the importance of tailoring surveillance intervals to individual patient risk profiles.

Source: Henry M et al.J Am Heart ⁤Assoc⁤ 2025; 14: e038821; https://www.ahajournals.org/doi/10.1161/JAHA.124.038821

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.